AtriCure Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | +172.2% | +369.8% | |
| – | +31.5% | +48.1% | -1.8% | -4.1% | +7.0% | +1.9% | +9.4% | +12.2% | +26.5% | +26.5% | +9.6% | |
| – | +18.8% | +30.0% | +24.9% | +12.9% | +9.0% | +25.9% | +24.0% | +2.5% | +24.2% | +13.1% | +10.6% | |
| – | +3,605.0% | +39.1% | -20.8% | -42.4% | +124.8% | +70.7% | -408.1% | – | – | – | – | |
| – | – | -295.1% | – | – | -429.9% | – | – | – | – | – | – | |
| – | +160.6% | -67.9% | -17.0% | -2.7% | +96.1% | -56.8% | +85.5% | +73.1% | +148.8% | -44.1% | -61.4% | |
| – | -65.7% | +15.0% | – | -2,370.8% | -97.5% | +7,175.2% | – | +87.2% | -50.4% | +38.6% | -148.1% | |
| – | -56.1% | +831.2% | -84.5% | +485.6% | -85.0% | +266.6% | -12.8% | -51.1% | -99.0% | -100.0% | – | |
| – | +136.3% | +117.5% | +18.3% | +121.4% | +102.7% | +44.2% | +38.2% | -32.3% | -46.3% | +6.0% | +60.6% | |
| – | -94.0% | – | -107.1% | – | +35.8% | -100.2% | – | -123.5% | +10.3% | +68.2% | -28.0% | |
| – | -78.8% | +98.4% | -90.0% | +3,529.6% | -85.7% | +1,217.7% | -104.0% | -7.6% | -99.5% | +11,159.4% | – | |
| – | -134.2% | – | -640.3% | – | -136.0% | – | -87.3% | +744.7% | +81.5% | +46.5% | +16.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.